Schedule 13G ownership disclosure
Kymera Therapeutics Inc
Common Stock · CUSIP: 501575104
Event date: 2026-09-30
- Filing-level shares
- 5,450,286
- Percent of class
- 6.6%
- BlackRock, Inc.
Shares: 5,450,286 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-003919
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Oct 27, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership